This move is archived. Current quotes and coverage live on the stock page.
Get AVCR alerts:
Avricore Health Inc is making waves on the TSXV with a remarkable 7.69% surge in stock price, closing at CA$0.07.
In today's trading session, Avricore Health Inc (AVCR.V) has caught the attention of investors with a notable increase in its stock price. This rise comes as the company continues to expand its efforts, particularly in the UK market.
Advertisement
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$6.95M
52W high
$0.10
52W low
$0.04
1W change
+27.27%
Beta
0.32
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
145.8%
Annualized
90-Day Vol
121.1%
Annualized
Trend (90d)
+31.1%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.04 – C$0.12 |
| 60 trading days | C$0.08 | C$0.04 – C$0.15 |
| 90 trading days | C$0.08 | C$0.03 – C$0.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on Avricore Health's strategic moves as it expands its HealthTab™ platform, which could lead to further growth and profitability in the future.
7.69% Gain in One Day
Avricore Health Inc's stock price increased from CA$0.065 to CA$0.07, reflecting strong positive sentiment among investors.
Bull case
The recent financing of CA$1.254 million shows strong investor confidence and provides the capital Avricore needs for its expansion plans, which could significantly boost its market presence.
Bear case
Despite today's gains, Avricore Health's profitability is still uncertain, with a profit margin of 0% and no dividends, which might discourage risk-averse investors.
Positive Momentum in Stock Performance
Advertisement
Avricore Health Inc's stock has seen a notable increase of 7.69% in the last trading session, closing at CA$0.07. This surge reflects growing interest in the company's innovative HealthTab™ platform, designed to enhance point-of-care testing in community pharmacies.
Strategic Expansion Plans
The recent financing of CA$1.254 million is a significant milestone for Avricore Health, providing essential funds to support its expansion initiatives in the UK. The company aims to broaden its HealthTab™ platform's reach, which has already screened over 3,500 patients, indicating strong demand for its services.
Future Outlook
As Avricore Health continues to innovate and expand its market presence, investors will want to monitor its financial performance and strategic developments. The company's ability to turn its growth initiatives into profitability will be crucial for maintaining investor confidence.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
